Orchestra BioMed Holdings Inc. (OBIO)
Healthcare
Biotechnology
4.00 $
-0.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Orchestra BioMed Holdings Inc. (OBIO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 54.7% of the shares are freely tradable; institutional investors hold 41.7%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
41.7%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
26.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
54.7%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
3.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
60Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RTW INVESTMENTS, LLC | 13.87 | 8,306,063 | +0.0 | 03/31/2026 |
| Perceptive Advisors LLC | 8.41 | 5,037,906 | -1.7 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.68 | 2,204,319 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 2.68 | 1,604,556 | +8.3 | 12/31/2025 |
| Alyeska Investment Group, L.P. | 1.67 | 1,000,000 | +0.0 | 03/31/2026 |
| Millennium Management LLC | 1.17 | 702,543 | +188.6 | 03/31/2026 |
| BlackRock Inc | 1.06 | 635,714 | +0.8 | 03/31/2026 |
| Geode Capital Management, LLC | 0.81 | 485,492 | +2.6 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.89 | 1,727,963 | +0.0 | 04/30/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.71 | 426,758 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.